104.6 USD
-1.1 (-1.04%)
104.6 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 86% to RYTM. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 128.38. This target is 22.74% above the current price.
RYTM was analyzed by 21 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about RYTM.
In the previous month the buy percentage consensus was at a similar level.
RYTM was analyzed by 21 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-25 | Citigroup | Initiate | Buy |
| 2025-11-10 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-11-07 | Needham | Maintains | Buy -> Buy |
| 2025-11-04 | Needham | Maintains | Buy -> Buy |
| 2025-10-17 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-10-16 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-09-29 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-09-25 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-09-25 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-09-24 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-08-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-08-06 | Guggenheim | Maintains | Buy -> Buy |
| 2025-08-06 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-08-06 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-07-18 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-07-10 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2025-07-10 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-07-10 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-07-10 | B of A Securities | Maintains | Buy -> Buy |
| 2025-07-09 | Needham | Maintains | Buy -> Buy |
| 2025-07-07 | Leerink Partners | Initiate | Outperform |
| 2025-06-26 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-05-29 | Stifel | Maintains | Buy -> Buy |
| 2025-05-07 | Needham | Maintains | Buy -> Buy |
| 2025-04-10 | B of A Securities | Maintains | Buy -> Buy |
| 2025-04-08 | Needham | Reiterate | Buy -> Buy |
| 2025-04-08 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-04-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-07 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-03-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
RHYTHM PHARMACEUTICALS INC / RYTM FAQ
Can you provide the average price target for RHYTHM PHARMACEUTICALS INC stock?
21 analysts have analysed RYTM and the average price target is 128.38 USD. This implies a price increase of 22.74% is expected in the next year compared to the current price of 104.6.
Can you provide the consensus rating for RHYTHM PHARMACEUTICALS INC stock?
The consensus rating for RHYTHM PHARMACEUTICALS INC (RYTM) is 85.7143 / 100 . This indicates that analysts generally have a positive outlook on the stock.